View Document Preview and Link Document Date: 2013-01-31 09:57:49 Open Document File Size: 1,81 MB Share Result on Facebook
City Bergisch Gladbach / Stockholm / Basel / Santa Cruz / Sollentuna / Cambridge / Fremont / London / Ta¨by / Solna / Go¨ttingen / / Company Hjelmeland AB / Vector Labs Inc. / D2 / Roche Diagnostics / Thermo Fisher Scientific / Millipore / Sigma-Aldrich / treatmentnaive LC / Odyssey Sa / Qiagen / Cheng LC / GE Healthcare / Pharmacia / CellQuest Software / Bethyl Laboratories / IgG / Karolinska Institutet Research Funds / Creative Commons / Macmillan Publishers Limited / / Country Switzerland / United Kingdom / Germany / Sweden / United States / / / Event Product Issues / / Facility Karolinska University Hospital / Uppsala University / checkpoint Characterization / / IndustryTerm active site / solute carrier family / lung cancer treatment / amplified product / damage response machinery / stem cell media / cell dissociation solution / cancer treatment / complementation / cellular signaling networks / damage signaling network / / MedicalCondition Laterra J. Cancer / lymphocytic leukemia / JE / large-cell and squamous carcinoma / mouse tumor / non-small-cell lung cancer / non-small cell lung cancer / lung adenocarcinoma / breast cancer / non-small cell lung cancer tumor / aggressive glioblastoma subtype / glioblastoma / adenocarcinoma / median tumor / tumor / large cell carcinomas / cancer / tumors / NSCLC / Varticovski L. Lung cancer / cisplatin-resistant human ovarian cancer / mock-treated bulk tumors / large cell/adenocarcinoma / human hepatocellular carcinoma / tumorigenic lung cancer / gastric cancer / Fanconi anemia / dimer dissociation / platinum-containing cancer / also called cancer / metastasis / glioma / stem-like cancer / self-renewing lung cancer / gliomas / cell dissociation solution / bulk tumors / MS / glioma and medulloblastoma tumor / ataxia / different tumor / squamous cell carcinoma / adenocarcinomas / Highly tumorigenic lung cancer CD133 / LC disease / Disease / Cancer Lung cancers / Mycobacterium tuberculosis / human lung cancer / large cell carcinoma / Female SCID / J Gynecol Cancer / assessed tumor / lung cancer / liver cancer / Disease TICs / SCID / / MedicalTreatment radiotherapy / radiation / chemo / chemotherapy / / MusicAlbum TICs / / Organization Department of Oncology-Pathology / Karolinska Biomics Center / Swedish National Board of Health and Welfare / Stockholm Cancer Society / European Union / Swedish Cancer Society / Stockholm County Council / Karolinska Institutet and Karolinska University Hospital / Swedish Research Council / Karolinska University Hospital / Roswell Park Memorial Institute / Animal Ethical committee in Stockholm / Uppsala University / / Person Lyle S. Quiescent / / / Position RT / representative / CT/RT / increased CT/RT / Tin VP / conventional CT/RT / driver / Increased RT / Sailor / Alfaro MP / Sweden *Corresponding author / Marshall / / Product cisplatin / Sigma / Puma / TICs / Polaroid a300 Digital Camera / activation / CT response / phosphorylation / cell cycle arrest / G2/M / checkpoint Characterization / / ProvinceOrState Connecticut / South Dakota / / PublishedMedium PLoS One / / Technology radiation / siRNA / stem cells / apoptosis / gene expression / chemotherapy / recombination / electrophoresis / antibodies / Biotechnology / ATM / Cell Signaling / / URL http / SocialTag 
Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest